Session: Crystallization of Pharmaceutical and Biological Molecules 2: In Honor of the Late Dr. Jeff Wei of Eli Lilly (2010 Annual Meeting)

Description:

Additional session to cope with high rate of submissions.

Sponsor:

Pharmaceuticals

Co-Sponsor(s):

Crystallization and Evaporation (02B)

Chair:

Derek Griffin
Associate Senior Consultant Engineer
Lilly Research Laboratories, Eli Lilly and Company
Chemical Product Research and Development
Lilly Corporate Center
Indianapolis, IN 46285
Phone Number: 317-655-8804
Fax Number: 317-651-6510
Email: griffindw@lilly.com

Co-Chair:

Ryan C. Snyder
Bucknell University
Department of Chemical Engineering
Lewisburg, PA 17837
Phone Number: 570-577-2346
Email: ryan.snyder@bucknell.edu

Papers:

Introductory Remarks

141a

A Streamlined Approach to Avoiding Oiling in Crystallization Processes of Api's and Intermediates
Mourad Hamedi, Merck and Co. Inc; Micaela Caramellino, New Jersey Institute of Technology; Kelvin Yong, Merck and Co. Inc; Xiaoyong Fu, Merck and Co. Inc

141b

Crystallization Development of a Pharmaceutical API through Implementation of Real-Time Supersaturation Feedback Control
James Vernille, Bristol-Myers Squibb Co; Jose Tabora, Bristol-Myers Squibb Co; Amanda Rogers, Bristol-Myers Squibb Co; Jacob Albrecht, Bristol-Myers Squibb Co; Richard D. Braatz, Massachusetts Institute of Technology; Mitsuko Fujiwara, University of Illinois at Urbana-Champaign

141c

Designing a Reactive Crystallization Process for An Agglomerating API
Jennifer Kuehne-Willmore, Eli Lilly and Company; Jeffrey Vicenzi, Eli Lilly and Company; Sarah O'Keeffe, Eli Lilly and Company; Douglas Kjell, Eli Lilly and Company

141d

Use of a Crystallization Modifier to Enhance Impurity Rejection in the Crystallization of a Pharmaceutical Intermediate
Ann M. Czyzewski, Abbott Laboratories; Shuang Chen, Abbott Laboratories; Su Yu, Abbott Laboratories; Ian Marsden, Abbott Laboratories; Chen Ding, Abbott Laboratories; Calvin Becker, Abbott Laboratories; James J. Napier, Abbott Laboratories

141e

Crystallization Tendency of Amorphous Pharmaceuticals Prepared by Rapid Solvent Evaporation: Classification, Comparison with Undercooled Melts and Interpretation in Terms of Physico-Chemical Drug Compound Characteristics
Bernard Van Eerdenbrugh, Purdue University; Jared Baird, Purdue University; Lynne Taylor, Purdue University

141f

Spiral Growth Model for Organic Crystals of Real Complexity: How to Account for Non-Isotropic Behavior
Zubin B. Kuvadia, University of California, Santa Barbara; Michael F. Doherty, University of California at Santa Barbara

141g

Population Balance Modeling of Morphology Distribution of Asymmetric Crystals
Meenesh R. Singh, Purdue University; Jayanta Chakraborty, Purdue University; Doraiswami Ramkrishna, Purdue University

See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division

<< Previous Session | Next Session >>